These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25113908)
1. HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain. Bolduan S; Reif T; Schindler M; Schubert U Virology; 2014 Sep; 464-465():375-384. PubMed ID: 25113908 [TBL] [Abstract][Full Text] [Related]
2. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. Matusali G; Potestà M; Santoni A; Cerboni C; Doria M J Virol; 2012 Apr; 86(8):4496-504. PubMed ID: 22301152 [TBL] [Abstract][Full Text] [Related]
3. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions. Yoshida T; Koyanagi Y; Strebel K J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238 [TBL] [Abstract][Full Text] [Related]
4. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells. Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670 [TBL] [Abstract][Full Text] [Related]
5. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. Vigan R; Neil SJ J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557 [TBL] [Abstract][Full Text] [Related]
6. Lack of adaptation to human tetherin in HIV-1 group O and P. Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466 [TBL] [Abstract][Full Text] [Related]
8. Vpu binds directly to tetherin and displaces it from nascent virions. McNatt MW; Zang T; Bieniasz PD PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949 [TBL] [Abstract][Full Text] [Related]
9. The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4 Pawlak EN; Dirk BS; Jacob RA; Johnson AL; Dikeakos JD Retrovirology; 2018 Jan; 15(1):6. PubMed ID: 29329537 [TBL] [Abstract][Full Text] [Related]
10. Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes. Umviligihozo G; Cobarrubias KD; Chandrarathna S; Jin SW; Reddy N; Byakwaga H; Muzoora C; Bwana MB; Lee GQ; Hunt PW; Martin JN; Brumme CJ; Bangsberg DR; Karita E; Allen S; Hunter E; Ndung'u T; Brumme ZL; Brockman MA J Virol; 2020 Jul; 94(14):. PubMed ID: 32376625 [TBL] [Abstract][Full Text] [Related]
11. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity. Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses. Prévost J; Pickering S; Mumby MJ; Medjahed H; Gendron-Lepage G; Delgado GG; Dirk BS; Dikeakos JD; Stürzel CM; Sauter D; Kirchhoff F; Bibollet-Ruche F; Hahn BH; Dubé M; Kaufmann DE; Neil SJD; Finzi A; Richard J mBio; 2019 Jun; 10(3):. PubMed ID: 31213558 [TBL] [Abstract][Full Text] [Related]
13. Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. Galaski J; Ahmad F; Tibroni N; Pujol FM; Müller B; Schmidt RE; Fackler OT J Acquir Immune Defic Syndr; 2016 May; 72(1):1-10. PubMed ID: 26656785 [TBL] [Abstract][Full Text] [Related]
14. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells. Lambelé M; Koppensteiner H; Symeonides M; Roy NH; Chan J; Schindler M; Thali M J Virol; 2015 Mar; 89(6):3247-55. PubMed ID: 25568205 [TBL] [Abstract][Full Text] [Related]
15. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. Rong L; Zhang J; Lu J; Pan Q; Lorgeoux RP; Aloysius C; Guo F; Liu SL; Wainberg MA; Liang C J Virol; 2009 Aug; 83(15):7536-46. PubMed ID: 19474106 [TBL] [Abstract][Full Text] [Related]
16. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700 [TBL] [Abstract][Full Text] [Related]
17. Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation. Bächle SM; Sauter D; Sibitz S; Sandberg JK; Kirchhoff F; Moll M Sci Rep; 2015 Apr; 5():9675. PubMed ID: 25872908 [TBL] [Abstract][Full Text] [Related]
18. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2. Hopfensperger K; Richard J; Stürzel CM; Bibollet-Ruche F; Apps R; Leoz M; Plantier JC; Hahn BH; Finzi A; Kirchhoff F; Sauter D mBio; 2020 Jul; 11(4):. PubMed ID: 32665270 [TBL] [Abstract][Full Text] [Related]
19. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs. Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374 [TBL] [Abstract][Full Text] [Related]